|
|
Studies
|
|
 |
|
New Programs(25 Records found)
CTO#: 101766
Status: Active/Enrolling Sponsor: RTOG (0938) A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Lay Description:
HIPAA Informed Consent
...details...
CTO#: 101747
Status: Active/Enrolling Sponsor: NSABP (P-5) Statin Polyp Prevention Trial in Patients with Resected Colon Cancer
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101746
Status: Active/Enrolling Sponsor: MUSC (TMS-2011-B) Characterization of Peripheral Blood Monocytosis and Reactive Lymphocytosis in Patients with Mast Cell Activation Syndrome (MCAS)
Lay Description: This study is evaluating if flow cytometric techniques can quickly and accurately distinguish mast cells from monocytes and reactive lymphocytes and provide the health care team a way to detect mast cell activation sydrome(MCAS) earlier and provide better outcomes. This study requires a blood sample from suspected MCAS patients.
HIPAA Informed Consent Protocol
...details...
CTO#: 101745
Status: Active/Enrolling Sponsor: MUSC (TMS-2011-A) Retrospective Characterization of Certain Blood Test Abnormalities Potentially Aiding the Diagnosis of Mast Cell Activation Disease (MCAD), Especially Mast Cell Activation Syndrome (MCAS)
Lay Description:
No Documents currently available
...details...
CTO#: 101716
Status: Active/Enrolling Sponsor: NCCTG (020221) A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
Lay Description:
No Documents currently available
...details...
CTO#: 101705 Lip, Oral Cavity and Pharynx Status: Active/Enrolling Sponsor: RTOG (1016) PHASE III TRIAL OF RADIOTHERAPY PLUS CETUXIMAB VERSUS CHEMORADIOTHERAPY IN HPV-ASSOCIATED OROPHARYNX CANCER
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101697
Status: Active/Enrolling Sponsor: Eli Lilly (I3X-MC-JHTC) A Phase 1 Study of LY2784544 Testing Alternative Dosing
Regimens in Patients with Myelofibrosis
Lay Description:
HIPAA Informed Consent Patient Materials Protocol Sub Study Consent
...details...
CTO#: 101669
Status: Active/Enrolling Sponsor: MUSC (Onyx IST-CAR-536) Phase 1/2A Study Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Lay Description:
No Documents currently available
...details...
CTO#: 101665 Brain and Nervous System Status: Active/Enrolling Sponsor: MUSC () The Efficacy of PF-02341066 (Crizotinib), a Dual ALK/c-Met Inhibitor in Inhibiting Growth of Glioblastoma
Lay Description:
No Documents currently available
...details...
CTO#: 101663
Status: Active/Enrolling Sponsor: CALGB (80803) RANDOMIZED PHASE II TRIAL OF PET SCAN-DIRECTED COMBINED MODALITY THERAPY IN ESOPHAGEAL CANCER
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101657
Status: Active/Enrolling Sponsor: SWOG (S1014) Abiraterone Acetate Treatment for Prostate Cancer Patients with a
PSA of More Than Four Following Initial Androgen Deprivation Therapy,
Phase II.
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101646
Status: Active/Enrolling Sponsor: Threshold Pharmaceuticals (TH-CR-406/SARC021) A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101640 Lip, Oral Cavity and Pharynx Status: Active/Enrolling Sponsor: RTOG (1008) A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101639 Other Hematopoietic Status: Active/Enrolling Sponsor: Incyte (INCB 18424-261) An Open Label Assessment of an Alternative Dosing Strategy of Ruxolitinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis and Post-Essential Thrombocythemia-Myelofibrosis
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101635 Breast-Female Status: Active/Enrolling Sponsor: MUSC () Feasibility Study of Breast Cancer Candidate Genes in Three Population Groups In South Carolina
Lay Description:
No Documents currently available
...details...
CTO#: 101633 Breast-Female Status: Active/Enrolling Sponsor: ECOG (E2108) A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101632
Status: Active/Enrolling Sponsor: MUSC () Impact of nutritional parameters on outcome after pediatric hematopoietic stem cell transplantation
Lay Description:
No Documents currently available
...details...
CTO#: 101629 Breast-Female Status: Active/Enrolling Sponsor: RTOG (1005) A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer.
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101628 Breast-Female Status: Active/Enrolling Sponsor: SWOG (S1007) A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Postive Nodes, Hormone Receptor-Positive and HER2 negative Breast Cancer with Recurrence Score of 25 or less.
Lay Description:
HIPAA Informed Consent_Step 1 Informed Consent_Step 2 Protocol
...details...
CTO#: 101626
Status: Active/Enrolling Sponsor: Oncothyreon Inc. (PX-866-003) Phase 1/2 study of PX-866 and cetuximab
Lay Description:
HIPAA Informed Consent Patient Instructions Protocol
...details...
CTO#: 101625
Status: Active/Enrolling Sponsor: MUSC () The Accuracy of Virtual Guided Bronchoscopy (Broncus) compared to Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for Mediastinal Lymph Nodes
Lay Description:
No Documents currently available
...details...
CTO#: 101622 Breast-Female Status: Active/Enrolling Sponsor: MUSC () Paclitaxel Induced Peripheral Neuropathy in Breast Cancer: Exploratory Study of the Role of Deoxysphingolipids
Lay Description:
HIPAA Informed Consent Protocol
...details...
CTO#: 101619 Lymphoid Leukemia, Non-Hodgkins Lymphoma Status: Active/Enrolling Sponsor: Sanofi-Aventis (TCD12012) A Phase 1b, multicenter, open-label, dose-escalation study of SAR245409 to evaluate the safety, tolerability, and clinical activity of SAR245409 in combination with bendamustine and/or rituximab in patients with relapsed or refractory indolent B-cell non Hodgkin lymphoma, mantle cell lymphoma, or chronic lymphocytic leukemia.
Lay Description:
Consent HIPAA Optional Consent Optional HIPAA Pregnant Partner HIPAA Protocol
...details...
CTO#: 101618 Breast-Female Status: Active/Enrolling Sponsor: Genentech, Inc. (GDC4950g) A PHASE II, DOUBLE-BLIND,PLACEBO-CONTROLLED, RANDOMIZED STUDY
OF GDC-0941 OR GDC-0980 WITH FULVESTRANT VERSUS FULVESTRANT IN
ADVANCED OR METASTATIC BREAST CANCER IN PATIENTS RESISTANT TO AROMATASE INHIBITOR THERAPY
Lay Description:
HIPAA Main Consent Optional Consent Protocol Spanish HIPAA Spanish Informed Consent Spanish Patient Materials
...details...
CTO#: 101616
Status: Active/Enrolling Sponsor: MUSC () Exploration of the Association of Periodontal Disease and Colorectal Neoplasia
Lay Description:
No Documents currently available
...details...
|
|
|
|
|
|
 |